← all works
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Cell
- Topic
- SARS-CoV-2 and COVID-19 Research
- Field
- Medicine
- Canadian institutions
- University of British ColumbiaUniversity of TorontoSt. Michael's HospitalStemcell Technologies
- Funders
- H2020 Marie Skłodowska-Curie ActionsEuropean Research CouncilCanadian Institutes of Health ResearchInstituto de Salud Carlos IIICentro de Investigación Biomédica en Red de CáncerFundación Científica Asociación Española Contra el Cáncer
- Keywords
- BiologyVero cellSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyAngiotensin-converting enzyme 2CoronavirusRecombinant DNAReceptorCoronavirus disease 2019 (COVID-19)LungOrganoidBetacoronavirusHEK 293 cells2019-20 coronavirus outbreakVirusImmunologyGeneCell biologyInternal medicineMedicineGenetics
- Has abstract in OpenAlex
- no